COLLCollegium Pharmaceutical, Inc.

COLL Stock Price, Valuation & Chart | Collegium Pharmaceutical, Inc.

$24.300+0.30 (+1.25%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic COLL intrinsic value COLL calculated fair value vs price

Overview Financials Dividends Ratios

COLL Historical price chart

COLL Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization788.14M

PE Ratio3.05

EPS7.97

Trading Volume841.42K

Today's High/Low24.82/23.84

Dividend Yield0.00

52 Week High/Low50.79/23.85

Shares Outstanding32.43M

COLL Financial Statement

COLL Analyst ratings

COLL Analysis & performance metrics

COLL Company profile

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an…

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe…

COLL Management team

Name

Position

David Dieter

Executive Vice President, General Counsel & Corporate Secretary

Scott Sudduth

Head of Technical Operations

Colleen TupperCFO

Executive Vice President & Chief Financial Officer

Dean J. Patras

Chief People Officer

Scott Dreyer

Executive Vice President & Chief Commercial Officer

Michael Thomas Heffernan B.S. Pharm, R.Ph.

Co-Founder & Chairman

Jane Gonnerman

Executive Vice President of Strategy & Corporate Development

Vikram KarnaniCEO

Chief Executive Officer, President, Executive Vice President & Director

Name

Position

David Dieter

Executive Vice President, General Counsel & Corporate Secretary

Scott Sudduth

Head of Technical Operations

Colleen TupperCFO

Executive Vice President & Chief Financial Officer

Dean J. Patras

Chief People Officer

Scott Dreyer

Executive Vice President & Chief Commercial Officer

Michael Thomas Heffernan B.S. Pharm, R.Ph.

Co-Founder & Chairman

Jane Gonnerman

Executive Vice President of Strategy & Corporate Development

Vikram KarnaniCEO

Chief Executive Officer, President, Executive Vice President & Director

Management Team

David Dieter

Executive Vice President, General Counsel & Corporate Secretary

Scott Sudduth

Head of Technical Operations

Colleen TupperCFO

Executive Vice President & Chief Financial Officer

Dean J. Patras

Chief People Officer

Scott Dreyer

Executive Vice President & Chief Commercial Officer

Michael Thomas Heffernan B.S. Pharm, R.Ph.

Co-Founder & Chairman

Jane Gonnerman

Executive Vice President of Strategy & Corporate Development

Vikram KarnaniCEO

Chief Executive Officer, President, Executive Vice President & Director

Management

David Dieter

Executive Vice President, General Counsel & Corporate Secretary

Scott Sudduth

Head of Technical Operations

Colleen TupperCFO

Executive Vice President & Chief Financial Officer

Dean J. Patras

Chief People Officer

Scott Dreyer

Executive Vice President & Chief Commercial Officer

Michael Thomas Heffernan B.S. Pharm, R.Ph.

Co-Founder & Chairman

Jane Gonnerman

Executive Vice President of Strategy & Corporate Development

Vikram KarnaniCEO

Chief Executive Officer, President, Executive Vice President & Director

Total 8 executives

COLL Frequently asked questions

What is Collegium Pharmaceutical, Inc. (COLL) Stock Price?

Current stock price of Collegium Pharmaceutical, Inc. (COLL) stock is $24.300. The stock price is +1.25% higher in the session. The intraday range can be seen from this page. Volume of Collegium Pharmaceutical, Inc. (COLL) stock is 841.42K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Collegium Pharmaceutical, Inc. (COLL) stock price going up or down today?

The stock price of Collegium Pharmaceutical, Inc. (COLL) can change with earnings, company news, and overall market sentiment. Collegium Pharmaceutical, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Collegium Pharmaceutical, Inc. stock expensive at its current price?

Whether Collegium Pharmaceutical, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for COLL on this page is 3.05. EPS on this page is 7.97. Compare those figures with peers and growth expectations before deciding if the current Collegium Pharmaceutical, Inc. price is justified.

How has the stock price of Collegium Pharmaceutical, Inc. (COLL) performed historically?

Historical performance for Collegium Pharmaceutical, Inc. (COLL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how COLL reacted to past earnings and market events.

Should I buy Collegium Pharmaceutical, Inc. (COLL) stock, at this price?

Buying Collegium Pharmaceutical, Inc. (COLL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.